Increasingly vocal and committed advocacy for medical marijuana has made cannabis use a hot button topic. Yet, although the issue is increasingly gaining support, medical cannabis remains a stigmatized medicine. This stigma goes beyond the tired notion of couch potatoes raiding whatever may be available in the kitchen cabinet, and has actually affected how – and if – patients can obtain medical cannabis. Perhaps even more harmful though, is the effect the marijuana stigma has on the ability of scientists to conduct research into the medical benefits of the cannabis plant.
- Grow at home patients begin harvesting plants
- THC Announces $10,000,000 Capital Commitment
- THC BioMed Begins Shipping Live Cannabis Plants across Canada to ACMPR Registered Patients and Announces Wholesale Genetic Pricing
- Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing – THC to Expand its Facilities
- Clone Shippers Scheduled for Delivery to THC BioMed